Monday, September 13, 2010

ZYDUS WELLNESS = Q1 FY 11 RESULTS = GOOR PROGRESS FROM Q1 FY 10 = FUTURE LOOKS VERY PROMISING


ZYDUS Wellness Limited
NSE Symbol    ZYDUSWELL
Q 1FY10 REVIEW
INTRODUCTION
Zydus Wellness manufactures markets wellness consumer products in India. Its specialty skincare products include face wash, facial masks, scrubs, sun blocks, winter care body lotion and cream, cleansers and toners, and men skin care comprising face washes, sun blocks, moisturizers, and scrubs under the EverYuth Naturals name;
It offers sugar alternatives and substitutes under the Sugar Free Gold, Sugar Free Natura, Sugar Free Tea'Lite ready to drink and powder drink names.
It provides health foods, like table margarine, poly unsaturated fatty acids, and mono unsaturated fatty acids under the Nutralite name.
Zydus Wellness Limited was formerly known as Carnation Nutra-Analogue Foods Limited and changed its name on January 5, 2009. The company is based in Ahmedabad, India. Zydus Wellness Limited operates as a subsidiary of Cadila Healthcare Limited.
REVIEW OF Q1 RESULTS
Zydus Wellness Ltd., posted excellent results in Q1 of FY 11, with sales up by 36.1% Y-OY to Rs. 87.32 Cr from Rs. 64,15 Cr. Net profit was up by 52.4 % to Rs. 7.65 Cr from Rs. 5.02 Cr (in Q1 FY10).
The growth in topline and bottomline was boosted by the new variants recently launched and a robust performance from the company’s pillar brands - Sugar Free, EverYuth and Nutralite.
The company’s summer launch Sugar Free TeaLite, is positioned at customers who are actively seeking healthier and lighter beverage options beyond the aerated segment. Flavoured sachets of Sugar Free, was another innovation in the sweetener segment.
Sugar Free, India’s largest selling sugar substitute continues to dominate the market. Sugar Free Gold, the aspartame based variant, and Sugar Free Natura, the Sucralose based variant, are expected to improve their performance with the festive season ahead.
EverYuth range of niche skincare products also continued to grow rapidly. Golden Glow Peel Off mask, Face Scrubs and Face Washes maintained their respective market shares.
The Menz range of exclusive skin-care for men continued to gain new grounds. During the quarter, the company also introduced a range of hand sanitisers.
Nutralite - the healthier alternative to butter, also fared well both in the retail and the institutional segments. With a continued thrust on market creation and brand building,
The company says – it aims to be a Rs. 500 crore company by FY 2013-14.


RESULTS IN NUMBERS
We can see the current position from the numbers below and the ratios given – Figures for Q1 FY11, Q4, FY10, their difference in % terms, figures for Q3 FY10, Figures for total FY10 and proportionate difference between (Q1 FY 11 x 4) and FY 10.
Net sales has improved by 38% compared to preceding Qtr and by 31% proportionately compared to FY10.
But, there is a huge increase of 206.8% under Other Expenditure in current Qtr compared to previous qtr and by 74.81% compared proportionately with the whole of FY10.
Due to this item pf other expenditure, the Net profits are down
Net Profit is Rs.7.65 Cr – down by 56.08% from previous qtr( Rs.17.42 Cr) and by 31.41% proportionately compared to FY10 total (Rs.45.27Cr).
Generally, such increase in Other expenditure tend to be a one time affair and subsequent quarters return to normal levels. Thus, there could be excellent results in Q2 FY11.
The extract from the company’s review at the beginning was with Q1 FY2010, which is the corresponding Qtr. With reference to that corresponding Qtr, the performance is very good. The company is expanding its sales every quarter in an excellent manner. Future appears to be quite promising.


Jun-10
Mar-10
Dif%1
Dec-09
Dif%2
Net Sales
8732
6341
37.71
7509
26752
30.56
Other Optg Income
9
26
-65.38
25
55
-34.55
SIT & WIP
193
-236
-181.8
-146
-510
-251.37
 Raw Materials
861
1039
-17.13
1220
3735
-7.79
Traded Goods
1785
1304
36.89
1356
5397
32.3
Employees Cost
283
223
26.91
246
931
21.59
Depreciation
35
35
0
34
159
-11.95
Other Expen
4602
1500
206.8
2787
10530
74.81
Total Expenditure
7759
3865
100.75
5497
20242
53.32
O P T
982
2502
-60.75
2037
6565
-40.17
Other Income5
165
215
-23.26
134
595
10.92
P B I & EI
1147
2717
-57.78
2171
7160
-35.92
Interest6
2
5
-60
2
9
-11.11
ProfitA I B B EI
1145
2712
-57.78
2169
7151
-35.95
Profit before tax
1145
2712
-57.78
2169
6931
-33.92
Tax expense
380
970
-60.82
737
2404
-36.77
Net Profit after tax
765
1742
-56.08
1432
4527
-32.41
Extraordinary Items
-
-

-
-

Net Profit
765
1742
-56.08
1432
4527
-32.41
Dividend (%)
-
30

-
30

Face Value
10
10
0
10
10

Paid Up Equity
3907
3907
0
3907
3907

Reserves
-
-

-
6151

Basic EPS A EI
1.96
4.46
-56.05
3.67
11.59
-32.36
Diluted EPS A EI
1.96
4.46
-56.05
3.67
11.59
-32.36
Basic EPS B EI
1.96
4.46
-56.05
3.67
11.59
-32.36
Diluted EPS B EI
1.96
4.46
-56.05
3.67
11.59
-32.36
Public holding (%)
27.49
27.49
0
27.49
27.49


ANNOUNCEMENTS
TO THE NSE
4-08-2010          Zydus Wellness Limited has submitted to the Exchange vide its letter dated August 10, 2010 a copy of investors presentation proposed to be made by Mr. Anand G. Deo, Managing Director of the Company to certain investors of the Company.
16-07-2010        Zydus Wellness Limited has informed the Exchange regarding a press release dated July 16, 2010, titled "Zydus Wellness' Net Profit up by 52.4% in Q1".
28-04-2010        Zydus Wellness Limited has informed the Exchange regarding a press release dated April 28, 2010, titled "Zydus Wellness' Net Profit jumps by 90% in FY'10".
28-04-2010        Zydus Wellness Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on April 28, 2010 have recommended a dividend of Rs.3/- (At the rate of 30%) per equity share on 39072089 equity share of Rs.10 each.        -
25-01-2010        Zydus Wellness Limited has informed the Exchange regarding a press release dated January 25,2010, titled "Zydus Wellness' Net Profit up by 105 % in Q3".

*  *  *    E N D    *  *  *

No comments:

Post a Comment